Federal Register of Legislation - Australian Government

Primary content

PB 113 of 2019 Determinations/Health as made
This instrument remakes and improves the operation of the National Health (Subsection 84C(7)) Determination 2010 before it sunsets.
Administered by: Health
Registered 29 Jan 2020
Tabling HistoryDate
Tabled HR04-Feb-2020
Tabled Senate04-Feb-2020
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 113 of 2019

 

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019

I, Adriana Platona, as delegate of the Minister for Health, make the following determination.

Dated 23 January 2020

Adriana Platona
First Assistant Secretary
Technology Assessment and Access Division

Department of Health

 

  

  

  


Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

5............ Definitions..................................................................................................................... 1

6............ Manner of ascertaining price for pharmaceutical benefits.............................................. 2

Schedule 1—Repeals                                                                                                                                       3

National Health (Subsection 84C(7)) Determination 2010                                                          3

 


1  Name

             (1)  This instrument is the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019.

             (2)  This instrument may also be cited as PB 113 of 2019.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 February 2020.

1 February 2020

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 84C(7) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

5  Definitions

                   In this instrument:

Act means the National Health Act 1953.

additional patient charge has the same meaning as in the National Health (Pharmaceutical Benefits) Regulations 2017.

admixed ready‑prepared pharmaceutical benefit means a pharmaceutical benefit mentioned in Schedule 1 to the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019).

approved pharmacist has the meaning given by subsection 84(1) of the Act.

extemporaneously‑prepared pharmaceutical benefit means a pharmaceutical benefit that is not a ready‑prepared pharmaceutical benefit.

pharmaceutical benefit has the meaning given by subsection 84(1) of the Act.

ready‑prepared pharmaceutical benefit means a brand of a pharmaceutical item determined under subsection 85(6) of the Act.

6  Manner of ascertaining price for pharmaceutical benefits

             (1)  For the purposes of subsection 84C(7) of the Act, the price for a pharmaceutical benefit (of a particular quantity or number of units) is to be ascertained by adding:

                     (a)  the Commonwealth price for the supply of the benefit by an approved pharmacist, worked out in accordance with the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2015 (PB 64 of 2015); and

                     (b)  the amount of the additional patient charge; and

                     (c)  either:

                              (i)  if the pharmaceutical benefit is a ready‑prepared pharmaceutical benefit, other than an admixed ready‑prepared pharmaceutical benefit—$1.25; or

                             (ii)  if the pharmaceutical benefit is an extemporaneously‑prepared pharmaceutical benefit or an admixed ready‑prepared pharmaceutical benefit—$1.61.

Note:          This subsection complies with subsection 84C(8) of the Act because, to comply with subsection 98B(2) of the Act, the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2015 (PB 64 of 2015):

(a)    uses as a basis the approved ex‑manufacturer price, a proportional ex‑manufacturer price or the basic wholesale price; and

(b)    provides for the addition of other fees and amounts determined by the Tribunal that made the determination.

             (2)  However, the price for the pharmaceutical benefit must not be more than the amount that an approved pharmacist may charge for the supply of the benefit under subsection 87(2) or (3) of the Act.


Schedule 1Repeals

  

National Health (Subsection 84C(7)) Determination 2010

1  The whole of the instrument

Repeal the instrument.